Functions of platelet glycoprotein (GP) -Ib determined by a monoclonal anti-GP-Ib antibody, TM60
Tanoue, K.; Yamatoto, N.; Kitagawa, H.; Yamamoto, K.; Suzuki, H.; Yamazaki, H.
Nihon Ketsueki Gakkai Zasshi Journal of Japan Haematological Society 50(3): 706-711
1987
ISSN/ISBN: 0001-5806 PMID: 3425186 Document Number: 286485
Document emailed within 1 workday
Related Documents
Ikeda, Y.; Furihata, K.; Imai, M.; Sugiura, K.; Toyama, K.; Yamamoto, M.; Watanabe, K.; Ando, Y. 1981: Effect of anti-platelet tubulin antibody on platelet functions Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 44(3): 652-657Perutelli, P.; Marchese, P.; Mori, P.G. 1992: Monoclonal antibody-induced platelet aggregation does not require interaction between antibody and platelet Fc receptor Haematologica 77(2): 186-187
Sugiyama, Y.; Chen, F.A.; Takita, H.; Bankert, R.B. 1988: Selective growth inhibition of human lung cancer cell lines bearing a surface glycoprotein gp160 by 125I-labeled anti-gp160 monoclonal antibody Cancer Research 48(10): 2768-2773
Higashihara, M.; Maeda, H.; Ohashi, T.; Oka, H.; Kume, S. 1987: The effect of a monoclonal antibody specific for human platelet GPIIb/IIIa (TP80) on platelet function Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 50(4): 926-935
van der Heijden, R.W.; Bunschoten, H.; Pascual, V.; Uytdehaag, F.G.; Osterhaus, D.M.; Capra, J.D. 1990: Nucleotide sequence of a human monoclonal anti-idiotypic antibody specific for a rabies virus-neutralizing monoclonal idiotypic antibody reveals extensive somatic variability suggestive of an antigen-driven immune response Journal of Immunology 144(7): 2835-2839
Barel, M.; Fiandino, A.; Delcayre, A.X.; Lyamani, F.; Frade, R. 1988: Monoclonal and anti-idiotypic anti-EBV/C3d receptor antibodies detect two binding sites, one for EBV and one for C3d on glycoprotein 140, the EBV/C3dR, expressed on human B lymphocytes Journal of Immunology 141(5): 1590-1595
Tsuji, T.; Kimura, Y.; Murakami, T.; Sasaki, K.; Shinozaki, F. 1990: An immunohistochemical evaluation of Warthin's tumor using the monoclonal anti-human lung adenocarcinoma antibody KM-93 and the anti-human gastric carcinoma antibody KM-231 Gan no Rinsho. Japan Journal of Cancer Clinics 36(7): 783-786
Izumi, T.; Pound, M.L.; Su, Z.; Iverson, G.M.; Ortel, T.L. 2002: Anti-beta(2)-glycoprotein i antibody-mediated inhibition of activated protein C requires binding of beta(2)-glycoprotein i to phospholipids Thrombosis and Haemostasis 88(4): 620-626
Swanson, R.A.; Tracy, R.P.; Katzmann, J.A.; Wilson, D.M.; Young, D.S. 1982: Beta 2-microglobulin determined by radioimmunoassay with monoclonal antibody Clinical Chemistry 28(10): 2033-2039
Kutok, J.L.; Coller, B.S. 1994: Partial inhibition of platelet aggregation and fibrinogen binding by a murine monoclonal antibody to GPIIIa: requirement for antibody bivalency Thrombosis and Haemostasis 72(6): 964-972
Perussia, B.; Acuto, O.; Terhorst, C.; Faust, J.; Lazarus, R.; Fanning, V.; Trinchieri, G. 1983: Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. II. Studies of B73.1 antibody-antigen interaction on the lymphocyte membrane Journal of Immunology 130(5): 2142-2148
Perosa, F.; Scudeletti, M.; Imro, M.A.; Dammacco, F.; Luccarelli, G.; Indiveri, F. 1997: Anti-CD4 monoclonal antibody (mAb) and anti-idiotypic mAb to anti-CD4 in the therapy of autoimmune diseases Clinical and Experimental Rheumatology 15(2): 201-210
Arvieux, J.; Roussel, B.; Pouzol, P.; Colomb, M.G. 1993: Platelet activating properties of murine monoclonal antibodies to beta 2-glycoprotein i Thrombosis and Haemostasis 70(2): 336-341
Byzova, T.V.; Vlasik, T.N.; Mazurov, A.V. 1994: Inhibition of platelet aggregation with monoclonal antibodies to the glycoprotein IIb-IIIa complex Biulleten' Eksperimental'noi Biologii i Meditsiny 118(10): 402-405
Kitagawa, H.; Yamamoto, N.; Yamamoto, K.; Tanoue, K.; Kosaki, G.; Yamazaki, H. 1989: Involvement of platelet membrane glycoprotein Ib and glycoprotein IIb/IIIa complex in thrombin-dependent and -independent platelet aggregations induced by tumor cells Cancer Research 49(3): 537-541
Bemelmans, M.H.; Abramowicz, D.; Gouma, D.J.; Goldman, M.; Buurman, W.A. 1994: In vivo T cell activation by anti-CD3 monoclonal antibody induces soluble TNF receptor release in mice. Effects of pentoxifylline, methylprednisolone, anti-TNF, and anti-IFN-gamma antibodies Journal of Immunology 153(2): 499-506
Sawada, T.; Hashimoto, S. 2007: Human monoclonal antibody to B-lymphocyte stimulator (belimumab) and humanized anti-LFA-1 monoclonal antibodies (efalizumab) Nihon Rinsho. Japanese Journal of Clinical Medicine 65(7): 1239-1242
Johnson, V.G.; Schlom, J.; Paterson, A.J.; Bennett, J.; Magnani, J.L.; Colcher, D. 1986: Analysis of a human tumor-associated glycoprotein (TAG-72) identified by monoclonal antibody B72.3 Cancer Research 46(2): 850-857
Thor, A.; Gorstein, F.; Ohuchi, N.; Szpak, C.A.; Johnston, W.W.; Schlom, J. 1986: Tumor-associated glycoprotein (TAG-72) in ovarian carcinomas defined by monoclonal antibody B72.3 Journal of the National Cancer Institute 76(6): 995-1006
Shimodaira, H.; Komine, K.; Soeda, H.; Ishioka, C. 2010: Antibody-dependent cellular cytotoxicity in the immunotherapeutic mechanisms of anti-EGFR monoclonal antibody Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(5): 795-798